LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Tozasertib | 1.11 | uM | LJP5 | 2 | B15 | 72 | hr | 1235 | 1422 | 4578 | 0.3106 | 0.0770 |
MDA-MB-231 | Tozasertib | 1.11 | uM | LJP5 | 3 | B15 | 72 | hr | 1235 | 1292 | 4929 | 0.2621 | 0.0225 |
MDA-MB-231 | Tozasertib | 3.33 | uM | LJP5 | 1 | B14 | 72 | hr | 1235 | 1408 | 4474 | 0.3147 | 0.0727 |
MDA-MB-231 | Tozasertib | 3.33 | uM | LJP5 | 2 | B14 | 72 | hr | 1235 | 1557 | 4578 | 0.3401 | 0.1300 |
MDA-MB-231 | Tozasertib | 3.33 | uM | LJP5 | 3 | B14 | 72 | hr | 1235 | 1298 | 4929 | 0.2633 | 0.0248 |
MDA-MB-231 | Tozasertib | 10 | uM | LJP5 | 1 | B13 | 72 | hr | 1235 | 1259 | 4474 | 0.2814 | 0.0100 |
MDA-MB-231 | Tozasertib | 10 | uM | LJP5 | 2 | B13 | 72 | hr | 1235 | 1173 | 4578 | 0.2562 | -0.0273 |
MDA-MB-231 | Tozasertib | 10 | uM | LJP5 | 3 | B13 | 72 | hr | 1235 | 1353 | 4929 | 0.2745 | 0.0464 |
MDA-MB-231 | Imatinib | 0.04 | uM | LJP6 | 1 | N18 | 72 | hr | 1235 | 4127 | 4355 | 0.9474 | 0.9415 |
MDA-MB-231 | Imatinib | 0.04 | uM | LJP6 | 2 | N18 | 72 | hr | 1235 | 4458 | 4277 | 1.0422 | 1.0467 |
MDA-MB-231 | Imatinib | 0.04 | uM | LJP6 | 3 | N18 | 72 | hr | 1235 | 4365 | 4583 | 0.9524 | 0.9490 |
MDA-MB-231 | Imatinib | 0.12 | uM | LJP6 | 1 | N17 | 72 | hr | 1235 | 4241 | 4355 | 0.9736 | 0.9708 |
MDA-MB-231 | Imatinib | 0.12 | uM | LJP6 | 2 | N17 | 72 | hr | 1235 | 4404 | 4277 | 1.0296 | 1.0328 |
MDA-MB-231 | Imatinib | 0.12 | uM | LJP6 | 3 | N17 | 72 | hr | 1235 | 4333 | 4583 | 0.9454 | 0.9415 |
MDA-MB-231 | Imatinib | 0.37 | uM | LJP6 | 1 | N16 | 72 | hr | 1235 | 4515 | 4355 | 1.0365 | 1.0399 |
MDA-MB-231 | Imatinib | 0.37 | uM | LJP6 | 2 | N16 | 72 | hr | 1235 | 4501 | 4277 | 1.0523 | 1.0577 |
MDA-MB-231 | Imatinib | 0.37 | uM | LJP6 | 3 | N16 | 72 | hr | 1235 | 4082 | 4583 | 0.8906 | 0.8811 |
MDA-MB-231 | Imatinib | 1.11 | uM | LJP6 | 1 | N15 | 72 | hr | 1235 | 4337 | 4355 | 0.9957 | 0.9952 |
MDA-MB-231 | Imatinib | 1.11 | uM | LJP6 | 2 | N15 | 72 | hr | 1235 | 4458 | 4277 | 1.0422 | 1.0467 |
MDA-MB-231 | Imatinib | 1.11 | uM | LJP6 | 3 | N15 | 72 | hr | 1235 | 4044 | 4583 | 0.8823 | 0.8719 |
MDA-MB-231 | Imatinib | 3.33 | uM | LJP6 | 1 | N14 | 72 | hr | 1235 | 4373 | 4355 | 1.0039 | 1.0043 |
MDA-MB-231 | Imatinib | 3.33 | uM | LJP6 | 2 | N14 | 72 | hr | 1235 | 4376 | 4277 | 1.0231 | 1.0256 |
MDA-MB-231 | Imatinib | 3.33 | uM | LJP6 | 3 | N14 | 72 | hr | 1235 | 4255 | 4583 | 0.9284 | 0.9229 |
MDA-MB-231 | Imatinib | 10 | uM | LJP6 | 1 | N13 | 72 | hr | 1235 | 4117 | 4355 | 0.9452 | 0.9389 |
MDA-MB-231 | Imatinib | 10 | uM | LJP6 | 2 | N13 | 72 | hr | 1235 | 4060 | 4277 | 0.9492 | 0.9426 |